These findings demonstrate that pS106-Rab12, which is an activator of LRRK2 and proxy for LRRK2 kinase activity, is elevated in DLB cases with more advanced amyloid-β and tau pathology. The gene discussed is LRRK2; the disease is Lewy body dementia.